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Idiopathic pulmonary hemosiderosis is a rare disorder that can occur at any age and is characterized by the triad of
hemoptysis, iron deficiency anemia and diffuse pulmonary infiltrates. The clinical course is exceedingly variable
especially in children and a substantial proportion of this age group is undiagnosed. It is probably due to the fact
that iron deficiency anemia may be the first and the only manifestation of IPH, preceding other symptoms and
signs by several months and IPH is not considered as a rare cause of anemia, unless the typical triad is present. We
present a case of IPH in a 13-year-old girl, treated for several months with persistent iron deficiency anemia, without
response to therapy.
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Idiopathic pulmonary hemosiderosis (IPH) is a rare and life
threatening condition, found primarily in children, that
causes recurrent episodes of diffuse alveolar hemorrhage. It
is characterized by hemoptysis, alveolar infiltrates on chest
radiograph and various degrees of anemia, seen more
frequently in children than in adults [1-7]. The estimated
incidence of IPH in children is 0.24–1.23 cases per million,
with a mortality rate as high as 50%. Only 500 cases have
been described in medical literature [3,6,8]. When no
underlying cause for repeated episodes of diffuse alveolar
hemorrhage is apparent, the entity is referred to as
idiopathic pulmonary hemosiderosis [2]. The rarity of this
disease and the variable clinical course results in many
diagnostic pitfalls especially in children [9]. Late diagnosis
of IPH may allow complications and the beginning of
treatment at a stage when pulmonary fibrosis has already
developed, with consequently poorer prognosis [2,10].
Through our presentation we want to emphasize the
importance of early recognition of this syndrome.Case report
A 13-year-old girl was admitted in hospital after an episode
of faintness. At admission the girl presented very pale, with
extreme tiredness and unable to stay upright, with dyspnea* Correspondence: ilirjanabakalli@yahoo.com
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unless otherwise stated.and polipnea, unable to maintain oxygen saturation in
the air room (Sat O2 = 78%), with low blood pressure 80/
40 mmHg. For several months the girls has been treated for
iron deficiency anemia with oral administration of iron by
the hematologist, but without response to therapy. A month
ago, the child was again hospitalized for severe anemia with
blood transfusion. Given that at the age of 3 years, the child
was treated for idiopathic thrombocytopenic purpura (ITP),
the first suspicion was for menorrhagia, probably due to
chronic ITP, complicated with severe anemia. By the first la-
boratory data we observed: severe anemia with hemoglobin
level of 5.4 g/dL, Red Blood Cells (RBC) - 1.9 T/L, micro-
cytosis, hypochromia, with normal platelet number. The
value of mean corpuscular hemoglobin (MCH), mean cor-
puscular volume (MCV), mean cell hemoglobin concentra-
tion (MCHC) and serum iron were very low. Renal and liver
functions were normal. The electrocardiogram and the
echocardiogram were both normal. Bone marrow biopsy
shows hyperplastic erythropoiesis. No abnormality has been
observed by the gynecologist. The child’s condition has
deteriorated rapidly with significant respiratory failure. Chest
X-ray represents bilateral alveolar infiltrates. Despite that
there was no history for hemoptysis, clinical suspicion
before the triade (quick anemia, respiratory failure and low
levels of iron) was to pulmonary hemosiderosis. CT images
(Figure 1) and the presence of hemosiderin-laden macro-
phages called siderophages (pathognomonic of this disease)
in gastric lavage fluid confirmed the diagnosis of IPH.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 CT scan of the thorax showing diffuse alveolar interstitial infiltration.
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antinuclear antibodies (ANA), antineutrophil cytoplasmic
antibodies (ANCA), rheumatoid factor, anti-citrullinated
peptides (anti-CCP), antiglomerular basement membrane
(antiGBM), antigliadin, specific cow’s milk IgE and comple-
ment. Therapy with corticosteroids was initiated with a
partial and transient response. The girl presented with
recurrent episodes of dyspnea and severe anemia every
two-three months. Due to prolonged therapy, the girl
has become progressively cushingoid. Azathioprine, the
“second line” immunosuppressant recommended in IPH
[2], was subsequently introduced. Now clinical situation is
better controlled.
Discussion
The triad of iron deficiency anemia, hemoptysis and
diffuse infiltrates on chest - X ray, characterizes the onset
of IPH. However, any of these features may be the first
presenting manifestation and the clinical course is exceed-
ingly variable especially in children [11,12]. So, from a
Romanian experience of 15 children diagnosed with IPH
during a 22-year period (1984–2006), the classical triad
was found in only 4 cases [10]. On the other hand all pa-
tients, from the beginning had anemia and only 6 children
presented with pulmonary symptoms. Even in the French
RespiRare® cohort anemia and dyspnea were the most
frequent clinical features at the beginning (64% and 68%
respectively), while hemoptysis occurred only in 50% of
the patients [1].
Young children usually swallow their sputum; as a result,
hemoptysis is rare in children unless the bleeding issubstantial [1,4,8]. Even in our case we didn’t find the
presence of hemoptysis.
The age of presentation is bimodal, with a frequency peaks
in children less than five years of age and in adolescents
11 years or older.
A substantial proportion of the first group is undiagnosed.
It is probably due to not only to the lack of hemoptysis, but
to the fact that iron deficiency anemia may be the first and
the only manifestation of IPH, preceding other symptoms
and signs by several months [3,4,13,14]. Iron deficiency
anemia is the most common hematologic disorder seen in
childhood and IPH is not considered as a rare cause of
anemia, unless the typical triad is present [3,15].
Anemia in these cases is classical of iron deficiency, hypo-
chromic microcytic, due to chronic loss of blood. But if in
iron deficiency anemia, hematologic response to iron is
usually remarkable within the first month of therapy,
therapy failed during hemosyderosis [9]. As in our case, no
response to therapy and need for several transfusions has
been reported even in other cases [15-21]. Failure of iron
therapy and exclusion of its common causes, prompt us to
look at other diagnostic possibilities including IPH, even it
is a rare cause.
If bleeding is not substantial, pulmonary involvement may
not been found clinically at the beginning of the disease and
even chest X-ray may present normal, but with the develop-
ment of the disease, roentgenographic manifestations, once
abnormal, never return to normal although acute massive
infiltration partially resolve, making chest X-ray very useful
in such cases [1]. Unfortunately, we don’t have a chest X ray
of our case before the 2nd hospitalization.
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a better outcome when diagnosis is made at an early age
[3,10,15]. Due to the rarity of the disease and the variability
in clinical presentation, diagnosis is usually delayed. (Several
months in our case) Kipper et al. noted there is a long delay
(4 moths–10 years) between the starting of symptoms and
the time of correct diagnosis [22]. A mean delay of 2.4 years
before diagnosis was found in the Romanian experience
and 30 months in the Indian experience [10,19].
The gold standard for IPH diagnosis is lung biopsy [19].
On the other hand, diagnosis of IPH can be confirmed
by bronchoscopy with bronchoalveolar lavage, showing
hemosiderin-laden macrophages [6,23]. In our case con-
firmation of the diagnosis was made by the presence of
siderophages in gastric lavage fluid, which is equally diag-
nostic and also the simplest, reliable test in infants and
young children [6].
HR-CT scan are useful for early detection of pulmonary
fibrosis. Aggressive therapy is imperative to avoid pulmonary
fibrosis and mortality in these patients [24].
There are no evidence-based recommendations regarding
the treatment of IPH. As indicated in small case series and/
or case reports, corticosteroids are the mainstay treatment
of IPH [10,18]. It has been reported that corticosteroids are
associated with decreased pulmonary bleeding relapses and
pulmonary fibrosis [1,4,13]. Even though, there are contro-
versial and lack clear evidence in their favor. Other studies
suggest that they do not have any effect on the prognosis of
this disease [11]. In the Romanian experience treatment
with corticosteroids alone was not effective in 12 of 15
children [12]. Immunosuppressive therapies, mainly azathi-
oprine and hydroxychloroquine, are mostly proposed in sit-
uations of patients with steroid-refractory disease [1,23,25].
In our case corticosteroids were partially effective. Clinical
situation was better controlled with azathioprine in
combination with corticosteroids.
Yoachimescu et al. also concluded that azathioprine in
combination with corticosteroids might be the best thera-
peutic regimen, especially in preventing IPH exacerbations,
as in our case [8].
According to the Indian experience, treatment with
prednisolone and hydroxychloroquine were more effective
in the clinical course and the survival [25].
A 2007 scientific letter, reports preliminary success in
preventing pulmonary hemorrhage with the anti-oxidant
N-acetylcysteine [11].
The IPH and ITP may have occurred coincidentally in
this patient, but certain pathophysiological similarities
between these two disorders suggests that they are related.
In fact, according Mayo Clinic Internal Medicine, IPH has
been described in association with ITP, autoimmune
hemolytic anemia and celiac disease [26]. Even though the
etiology of IPH remains unknown, there is support for
an autoimmune contribution in IPH physiopathology. Inthe French RespiRare® cohort most of the patients had
autoimmune antibodies at onset or appeared during the
follow-up. (Anti-smooth-muscle antibodies SMA – 50% of
the tested patients, ANA – 45% and ANCA – 40%) [1].
Work-up for autoimmune antibodies in our case resulted
negative.
IPH prognosis seems to improve over time. While two
decades ago the mean survival was 3 years from diagnosis,
recent data show a 5-year survival in 86% of cases [3]. The
significant improvement is possibly due to the long-term
use of immunosuppressant therapy.
Conclusion
IPH although a rare entity, should be considered in patients
with long-term iron deficiency anemia. A chest X-ray is
compulsory in every unexplained iron deficiency anemia
exploration.
Pediatrician should keep in mind the possibility of
pulmonary hemosiderosis, in case of very quick anemia,
associated with early signs of respiratory failure.
Lack of hemoptysis does not exclude the diagnosis of
pulmonary hemosiderosis.
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